Net profit of RPG Life Sciences rose 21.09% to Rs 26.76 crore in the quarter ended June 2024 as against Rs 22.10 crore during the previous quarter ended June 2023. Sales rose 11.94% to Rs 165.42 crore in the quarter ended June 2024 as against Rs 147.78 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
Sales | 165.42 | 147.78 | 12 |
OPM % | 23.62 | 21.82 | - |
PBDT | 41.29 | 33.98 | 22 |
PBT | 36.00 | 29.77 | 21 |
NP | 26.76 | 22.10 | 21 |